Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 10, 2015, Pages 1828-1835.e1

  Bajaj, Jasmohan S ^a   Heuman, Douglas M ^a   Sterling, Richard K ^a   Sanyal, Arun J ^a   Siddiqui, Muhammad ^a   Matherly, Scott ^a   Luketic, Velimir ^a   Stravitz, R Todd ^a   Fuchs, Michael ^a   Thacker, Leroy R ^a   Gilles, HoChong ^a   White, Melanie B ^a   Unser, Ariel ^a   Hovermale, James ^a   Gavis, Edith ^a   Noble, Nicole A ^a   Wade, James B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Minimal Hepatic Encephalopathy; Screening; Stroop Test; TIPS

Indexed keywords

RIFAXIMIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; COVERT HEPATIC ENCEPHALOPATHY; ENCEPHALAPP STROOP TEST; EXTERNAL VALIDITY; FACE VALIDITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPONATREMIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POINT OF CARE TESTING; PORTOSYSTEMIC ANASTOMOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SMARTPHONE BASED STROOP TEST; STROOP TEST; TEST RETEST RELIABILITY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; COMPLICATION; POINT OF CARE SYSTEM; PROCEDURES; REPRODUCIBILITY; SMARTPHONE; TELEMEDICINE; VALIDATION STUDY;

ADULT; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SMARTPHONE; STROOP TEST; TELEMEDICINE;

EID: 84941744396     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.05.011     Document Type: Article

References (26)

1. Kappus M.R., Bajaj J.S. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 2012, 10:1208-1219.
2. Bajaj J.S., Etemadian A., Hafeezullah M., et al. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007, 45:833-834.
3. Amodio P., Schiff S., Del Piccolo F., et al. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 2005, 20:115-127.
4. Zhang L.J., Yang G., Yin J., et al. Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 2007, 48:577-587.
5. Felipo V., Ordono J.F., Urios A., et al. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 2012, 55:530-539.
6. Bajaj J.S., Thacker L.R., Heuman D.M., et al. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology 2013, 58:1122-1132.
7. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
8. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008, 47:596-604.
9. Bajaj J.S., Wade J.B., Sanyal A.J. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009, 50:2014-2021.
10. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001, 34:768-773.
11. Ortiz M., Jacas C., Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005, 42(Suppl):S45-S53.
12. Nabi E., Thacker L.R., Wade J.B., et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol 2013 Dec 19, Epub ahead of print.
13. Bajaj J.S., Riggio O., Allampati S., et al. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study. Clin Gastroenterol Hepatol 2013, 11:1511-1516.
14. Prasad S., Dhiman R.K., Duseja A., et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007, 45:549-559.
15. Bustamante J., Rimola A., Ventura P.J., et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999, 30:890-895.
16. Mullen K.D., Prakash R.K. Management of covert hepatic encephalopathy. Clin Liver Dis 2012, 16:91-93.
17. Bajaj J.S., Pinkerton S.D., Sanyal A.J., et al. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology 2012, 55:1164-1171.
18. Schiff S., D'Avanzo C., Cona G., et al. Insight into the relationship between brain/behavioral speed and variability in patients with minimal hepatic encephalopathy. Clin Neurophysiol 2014, 125:287-297.
19. Weissenborn K., Heidenreich S., Ennen J., et al. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001, 16:13-19.
20. Lauridsen M.M., Thiele M., Kimer N., et al. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis 2013, 28:231-234.
21. Bajaj J.S., Schubert C.M., Heuman D.M., et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010, 138:2332-2340.
22. Riggio O., Ridola L., Pasquale C., et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2010, 9:181-183.
23. Kircheis G., Knoche A., Hilger N., et al. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009, 137:1706-1715.
24. Riggio O., Nardelli S., Moscucci F., et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2012, 16:133-146.
25. Cardenas A., Gines P., Marotta P., et al. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol 2012, 56:571-578.
26. Ahluwalia V., Wade J.B., Thacker L., et al. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol 2013, 59:467-473.